In line with the breast cancer cell line data, we found that treatment of astrocytes with CQ resulted in significantly increased intracellular glycine levels compared to the VHC‐treated controls, providing cellular proof‐of‐concept of PHGDH activation by CQ. This evidence concerns the gene PHGDH and breast carcinoma.